Effectiveness and safety study of tezepelumab in adults & adolescent participants with severe asthma in the United States

Trial Identifier: D5180C00032
Sponsor: AstraZeneca
Collaborator:
Parexel
Start Date: April 2022
Primary Completion Date: October 2025
Study Completion Date: October 2025
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Spanish (United States) Translation

Trial Locations

Country Location
US, AL Mobile, AL, US, 36608
US, AZ Gilbert, AZ, US, 85234
US, CA Long Beach, CA, US, 90815
US, CA Los Angeles, CA, US, 90017
US, CA Rancho Mirage, CA, US, 92270
US, CA Westminster, CA, US, 92683
US, CO Colorado Springs, CO, US, 80907
US, CT New Haven, CT, US, 06510
US, DC Washington, DC, US, 20037
US, IL Chicago, IL, US, 60611
US, KY Lexington, KY, US, 40509
US, LA New Orleans, LA, US, 70112
US, MD Upper Marlboro, MD, US, 20772
US, MI Ann Arbor, MI, US, 48109
US, MI Ypsilanti, MI, US, 48197
US, MN Saint Paul, MN, US, 55109
US, MO Saint Louis, MO, US, 63110
US, NC Chapel Hill, NC, US, 27514
US, NC Wilmington, NC, US, 28401
US, NE Lincoln, NE, US, 68505
US, NE Omaha, NE, US, 68114
US, New York Hollis, New York, US, 11423
US, NY Horseheads, NY, US, 14845
US, NY Rochester, NY, US, 14642
US, NY Valhalla, NY, US, 10595
US, OH Toledo, OH, US, 43617
US, OK Oklahoma City, OK, US, 73120
US, PA Altoona, PA, US, 16602
US, PA Philadelphia, PA, US, 19140
US, RI Warwick, RI, US, 02886
US, SC Greenville, SC, US, 29607
US, TN Hendersonville, TN, US, 37075
US, TX Fort Worth, TX, US, 76104
US, TX Mckinney, TX, US, 75069
US, TX San Antonio, TX, US, 78229
US, VA Charlottesville, VA, US, 22903
US, WA Vancouver, WA, US, 98664